ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,466, issued on Dec. 23, was assigned to STEP PHARMA S.A.S. (Paris).
"Aminothiazole compounds as inhibitors of CTPS1" was invented by Andrew Novak (Nottingham, Great Britain) and Saleh Ahmed (Nottingham, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of formula (I): (I) and related aspects."
The patent was filed on April 18, 2023, under Application No. 18/302,259.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12503466&OS=12503466&RS=12503466
Disclaimer: Cu...